Exponent Eyes 2026 Growth on AI-Fueled Demand

Exponent ((EXPO)) has held its Q4 earnings call. Read on for the main highlights of the call.

Exponent’s latest earnings call painted an upbeat picture of a specialist engineering consultancy riding powerful secular trends in AI, electrification and energy infrastructure, even as it digests modest margin pressure and uneven performance in parts of the portfolio. Management highlighted a strong fourth quarter with improving revenue growth, expanding EBITDA margins, robust cash generation and sizeable capital returns to shareholders, while acknowledging higher operating costs, softer results in the Environmental & Health segment and elevated year‑end working capital that temporarily weighed on free cash flow.

Q4 Revenue Growth Strengthens Despite Calendar Headwinds

Exponent delivered a solid top line in the fourth quarter of 2025, with total revenues up 8% year over year to $147.4 million and net revenues (before reimbursements) rising 5% to $129.4 million. The quarter had a one‑week calendar headwind, reducing reported Q4 revenue by roughly 7% and full‑year revenue by about 1.3%. Adjusting for the shorter period, management said net revenue growth would have been in the low double digits, signaling that underlying demand is stronger than the headline numbers suggest and reinforcing the narrative of an accelerating exit from 2025.

Profitability and EBITDA Margins Tick Higher in Q4

Profitability improved in the quarter, with net income rising to $24.8 million, or $0.49 per diluted share, from $23.6 million, or $0.46 per share, a year earlier. Q4 EBITDA climbed to $34.7 million, and the EBITDA margin expanded to 26.8% of net revenues versus 25.2% in the prior‑year period. The margin improvement, despite a shorter quarter and rising operating expenses, suggests better pricing power, mix and utilization, and positions Exponent well heading into 2026 as it looks to recover full‑year margin compression.

Operational Metrics and Pricing Underscore Healthy Core Business

Key operating indicators underscored a healthy core consulting engine. Realized rate increases were about 5% in Q4 and for the full year, demonstrating Exponent’s ability to push through pricing in a still‑supportive demand environment. Average technical full‑time equivalent employees grew 5% in Q4 to 992, adding capacity for future revenue growth. Utilization improved slightly in the quarter to 69% from 68% a year ago, and management reiterated a higher utilization target going forward, signaling confidence that new headcount can be effectively absorbed.

Diverse Demand Across Proactive and Reactive Engagements

Demand remained well diversified between proactive and reactive work, reducing cyclicality and supporting a steady growth profile. On the proactive side, Exponent saw growth in user research for consumer electronics and in risk and asset integrity services for utilities, which benefit from ongoing innovation and regulatory scrutiny. Reactive services also expanded, particularly in failure analysis and dispute‑related engagements across energy, construction, transportation and life sciences. The company pointed to rising work tied to battery and electrification issues and data center failures, areas where complexity is increasing and where Exponent’s expertise is in high demand.

Engineering & Other Scientific Segment Drives Growth

The Engineering & other scientific segment, which accounts for about 85% of Q4 net revenues, continued to be the primary growth engine. Segment net revenues grew 7% in the quarter and 4% for the full year, supported by strong activity in utilities risk management, medical device regulatory advisory, consumer electronics user research and disputes work. This segment’s performance reflects Exponent’s positioning at the intersection of advanced engineering problems and regulatory and legal challenges, a niche that appears well aligned with long‑term trends in technology and infrastructure.

Cash Generation Fuels Generous Capital Returns

Exponent’s cash‑generation profile remained a key highlight. The company produced $131.7 million in cash from operations in 2025, giving it ample flexibility to return capital while investing for growth. Over the year, Exponent paid $61.5 million in dividends and repurchased $97.8 million of its shares at an average price of $72.22, signaling management’s confidence in the intrinsic value of the business. The balance sheet remains strong with $221.9 million in cash and cash equivalents at year‑end, providing a buffer against volatility and room for continued shareholder returns and strategic investments.

AI Tailwinds and Strategic Differentiation

Management devoted meaningful time to the impact of AI on Exponent’s business, describing it as a durable demand tailwind across consumer electronics, transportation, energy and life sciences. The company is using AI internally to drive efficiency, but its primary edge lies in its PhD‑heavy, multidisciplinary teams that can diagnose and solve complex physical‑system failures increasingly entangled with software and AI. As systems grow more interconnected and failure risks more consequential, Exponent’s combination of deep technical expertise and real‑world failure analysis experience is being positioned as a competitive differentiator unlikely to be commoditized by AI tools themselves.

Full-Year Revenue Growth Tempered by Net Income Decline

For the full year 2025, Exponent’s growth story was more nuanced. Total revenues rose 4% to $582 million and net revenues climbed to $536.8 million, also up 4% year over year, signaling steady but not explosive expansion. However, net income slipped 3% to $106 million, or $2.07 per diluted share, from $109 million, or $2.11, in 2024. The decline reflects a mix of higher operating costs, softer Environmental & Health performance and some normalization in interest income and tax rate benefits, reminding investors that even high‑quality fee businesses are not immune to cost and mix headwinds.

Margin Compression Driven by One-Time Costs

While EBITDA for the year increased slightly to $148.1 million, Exponent’s full‑year EBITDA margin dipped by 80 basis points to 27.6% of net revenues. Management attributed the compression primarily to one‑time items, including a rescheduled managers meeting and a Phoenix lease renewal that drove higher noncash expenses. These factors weighed on reported profitability but are not expected to repeat at the same magnitude, providing some comfort that underlying margin power remains intact and may be recaptured as 2026 progresses.

Mixed Picture on Billable Hours and Utilization

Billable hours and utilization statistics painted a mixed picture. Q4 billable hours were about 357,000, down 1% year over year, but would have been up roughly 6% on a normalized basis without the shortened quarter, consistent with the adjusted revenue growth story. For the full year, however, billable hours fell around 2%, and utilization slipped to 72.5% from 72.9% in 2024. The modest utilization decline highlights some under‑leveraged capacity, but management’s 2026 guidance calls for higher utilization, suggesting there is room to improve revenue per head as demand continues to ramp.

Operating Expenses Rise on Travel and Lease Costs

Operating expenses moved higher and weighed on full‑year profitability. General and administrative expenses jumped 17% in Q4 and 12% for the year to $25.5 million, largely due to increased travel, meals and the managers meeting. Other operating expenses rose 1% in Q4 and 7% for 2025, driven in part by higher noncash lease‑related costs tied to the Phoenix facility. While some of these increases are a function of normalization post‑pandemic and strategic investments, investors will watch closely to see whether Exponent can restrain overhead growth relative to revenue in 2026.

Environmental & Health Segment Lags

The Environmental & Health segment, which accounts for roughly 15% of Q4 net revenues, was a soft spot. Revenues before reimbursements fell 5% in the fourth quarter and were approximately flat for the full year. Management cited the one‑week shorter quarter as a partial contributor to Q4 weakness, but the segment’s slower growth relative to Engineering underscores a more challenging demand environment in certain environmental and health‑related consulting areas. The performance gap between segments may encourage a sharper focus on mix and cross‑selling opportunities to better leverage Exponent’s broader capabilities.

Interest Income and Tax Rate Turn From Tailwind to Headwind

Below the operating line, financial items were less favorable than in recent years. Interest income in Q4 was $1.9 million, and full‑year interest income declined by about $694,000 to $9.3 million, reflecting lower average cash balances and changing rate dynamics. Meanwhile, the consolidated tax rate moved higher, to 27.4% in Q4 from 24.7% a year ago and to 28% for the full year from 26% in 2024. Management noted that accounting treatment of share‑based awards introduces volatility into the effective tax rate, turning what had been a tailwind into a mild headwind in 2025.

Working Capital and DSOs Temporarily Pressure Free Cash Flow

Working capital dynamics were another area of focus. Management pointed to elevated reimbursable expenses and higher days sales outstanding (DSOs) at year‑end, largely tied to the timing of studies that ramped near the close of the year. These factors temporarily compressed free cash flow conversion despite strong operating cash flow for the full year. Executives expressed confidence that DSOs will improve as the company moves into 2026, implying that the year‑end working capital build is more a timing issue than a structural change in client payment behavior.

Guidance Signals Confidence in 2026 Growth and Margins

Looking ahead, Exponent’s 2026 guidance was constructive and underpinned the positive tone of the call. Management expects net revenues to grow in the high single digits for both Q1 and the full year, outpacing 2025’s 4% growth. Q1 EBITDA margin is projected at 27.5%–28.5%, above the prior‑year quarter, with full‑year margins of 27.6%–28.1%, essentially flat to modestly higher than 2025. Average technical FTEs are expected to rise about 4% in Q1 and 4%–5% for the year, while utilization is guided to 75%–76% in Q1 and 72.5%–73% for 2026, in line to slightly above 2025 levels. Management also anticipates realized rate increases of 3%–3.5% for the year, steady interest and miscellaneous income, a tax rate around 28.5% and capital expenditures of $12 million–$14 million. Longer term, the company reiterated its ambition for sustained high single‑digit to low double‑digit organic growth with margin expansion and mid‑70s utilization, underscoring confidence in the durability of demand drivers.

In sum, Exponent’s earnings call balanced a clear message of strength in Q4 and constructive guidance with a candid acknowledgment of full‑year margin compression, cost inflation and segment‑level softness. For investors, the key takeaways are that demand in the company’s core engineering markets appears robust, AI and electrification trends are driving more complex, higher‑value assignments, and the balance sheet supports continued capital returns. Execution on utilization, expense discipline and Environmental & Health growth will be important watchpoints, but the overall tone and outlook suggest Exponent remains well positioned for steady, profitable growth in 2026 and beyond.